Nasdaq Welcomes Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) to The Nasdaq Stock Market

mc_072717_hires-1

Sienna Biopharmaceuticals CEO Frederick C. Beddingfield III, M.D., Ph.D. rings the Nasdaq Stock Market Closing Bell.

Format

JPEG

Source

Nasdaq, Inc.

Downloads